1. Prescribed fenoterol and death from asthma in Ncw Zealand. 1981-83. Case control study. Lancet 1989; i: 917-22. complex and depend on its degree and cause and on the individual's compensatory gaseous;Crane, J.; Pearce, N.E.; Flatt, A.; Burgess, C.; Jackson, R.; Kwong, T.; Ball, M.; Beasley, R.
2. Case-control study ofprescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax changes.7 These vary from an;Pearce, N.; Grainger, J.; Atkinson, M.; Crane, J.; Burgess, C.; Culling, C.,1990
3. Prescribed fenoterol and death from asthma in New Zealand 1981-7: a further case-control study;Grainger, J.; Woodman, K.; Pearce, N.; Crane, J.; Burgess, C.; Keane, A.;Thorax,1991
4. Lack of evidence for beta 2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma;Burgess, C.D.; Windom, H.H.; Pearce, N.; Marshall, S.; Beasley, R.; Siebers, R.W.L.;Am Rev Respir Dis,1991
5. Bronchodilator, cardiovascular and hypokalaemic effects of fenoterol, salbutamol and terbutaline in asthma;Wong, C.S.; Pavord, I.D.; Williams, J.; Britton, JR, Tattersfield; A.;Lancet,1990